Atypical hemolytic and uremic syndrome in Algeria: diagnostic difficulties and therapeutic constraints
Nephrol Ther. 2023 Nov 2;19(6):483-490. doi: 10.1684/ndt.2023.37.ABSTRACTAtypical Hemolytic Uremic Syndrome (aHUS) is a systemic disease due to dysregulation of the alternate complement pathway, mortality is estimated at 10% and more than 50% of patients progress to end-stage renal disease. The aim of this study was to summarize the clinical data and biological results as well as the evolution and management of patients with aHUS seen over a period of four years in one specialized department in Algeria. Our study was observational and longitudinal. The inclusion criteria were: the clinical-biological triad of aHUS and age ...
Source: Nephrologie and Therapeutique - November 2, 2023 Category: Urology & Nephrology Authors: Souad Chelghoum Farid Haddoum Kamel Djenouhat Mohamed-Taher Hamlaoui Nawel Adjlane Mourad Boukheloua Source Type: research
Atypical hemolytic and uremic syndrome in Algeria: diagnostic difficulties and therapeutic constraints
Nephrol Ther. 2023 Nov 2;19(6):483-490. doi: 10.1684/ndt.2023.37.ABSTRACTAtypical Hemolytic Uremic Syndrome (aHUS) is a systemic disease due to dysregulation of the alternate complement pathway, mortality is estimated at 10% and more than 50% of patients progress to end-stage renal disease. The aim of this study was to summarize the clinical data and biological results as well as the evolution and management of patients with aHUS seen over a period of four years in one specialized department in Algeria. Our study was observational and longitudinal. The inclusion criteria were: the clinical-biological triad of aHUS and age ...
Source: Nephrologie and Therapeutique - November 2, 2023 Category: Urology & Nephrology Authors: Souad Chelghoum Farid Haddoum Kamel Djenouhat Mohamed-Taher Hamlaoui Nawel Adjlane Mourad Boukheloua Source Type: research
Atypical hemolytic and uremic syndrome in Algeria: diagnostic difficulties and therapeutic constraints
Nephrol Ther. 2023 Nov 2;19(6):483-490. doi: 10.1684/ndt.2023.37.ABSTRACTAtypical Hemolytic Uremic Syndrome (aHUS) is a systemic disease due to dysregulation of the alternate complement pathway, mortality is estimated at 10% and more than 50% of patients progress to end-stage renal disease. The aim of this study was to summarize the clinical data and biological results as well as the evolution and management of patients with aHUS seen over a period of four years in one specialized department in Algeria. Our study was observational and longitudinal. The inclusion criteria were: the clinical-biological triad of aHUS and age ...
Source: Nephrologie and Therapeutique - November 2, 2023 Category: Urology & Nephrology Authors: Souad Chelghoum Farid Haddoum Kamel Djenouhat Mohamed-Taher Hamlaoui Nawel Adjlane Mourad Boukheloua Source Type: research
Atypical hemolytic and uremic syndrome in Algeria: diagnostic difficulties and therapeutic constraints
Nephrol Ther. 2023 Nov 2;19(6):483-490. doi: 10.1684/ndt.2023.37.ABSTRACTAtypical Hemolytic Uremic Syndrome (aHUS) is a systemic disease due to dysregulation of the alternate complement pathway, mortality is estimated at 10% and more than 50% of patients progress to end-stage renal disease. The aim of this study was to summarize the clinical data and biological results as well as the evolution and management of patients with aHUS seen over a period of four years in one specialized department in Algeria. Our study was observational and longitudinal. The inclusion criteria were: the clinical-biological triad of aHUS and age ...
Source: Nephrologie and Therapeutique - November 2, 2023 Category: Urology & Nephrology Authors: Souad Chelghoum Farid Haddoum Kamel Djenouhat Mohamed-Taher Hamlaoui Nawel Adjlane Mourad Boukheloua Source Type: research
Atypical hemolytic and uremic syndrome in Algeria: diagnostic difficulties and therapeutic constraints
Nephrol Ther. 2023 Nov 2;19(6):483-490. doi: 10.1684/ndt.2023.37.ABSTRACTAtypical Hemolytic Uremic Syndrome (aHUS) is a systemic disease due to dysregulation of the alternate complement pathway, mortality is estimated at 10% and more than 50% of patients progress to end-stage renal disease. The aim of this study was to summarize the clinical data and biological results as well as the evolution and management of patients with aHUS seen over a period of four years in one specialized department in Algeria. Our study was observational and longitudinal. The inclusion criteria were: the clinical-biological triad of aHUS and age ...
Source: Nephrologie and Therapeutique - November 2, 2023 Category: Urology & Nephrology Authors: Souad Chelghoum Farid Haddoum Kamel Djenouhat Mohamed-Taher Hamlaoui Nawel Adjlane Mourad Boukheloua Source Type: research
Atypical hemolytic and uremic syndrome in Algeria: diagnostic difficulties and therapeutic constraints
Nephrol Ther. 2023 Nov 2;19(6):483-490. doi: 10.1684/ndt.2023.37.ABSTRACTAtypical Hemolytic Uremic Syndrome (aHUS) is a systemic disease due to dysregulation of the alternate complement pathway, mortality is estimated at 10% and more than 50% of patients progress to end-stage renal disease. The aim of this study was to summarize the clinical data and biological results as well as the evolution and management of patients with aHUS seen over a period of four years in one specialized department in Algeria. Our study was observational and longitudinal. The inclusion criteria were: the clinical-biological triad of aHUS and age ...
Source: Nephrologie and Therapeutique - November 2, 2023 Category: Urology & Nephrology Authors: Souad Chelghoum Farid Haddoum Kamel Djenouhat Mohamed-Taher Hamlaoui Nawel Adjlane Mourad Boukheloua Source Type: research
Atypical hemolytic and uremic syndrome in Algeria: diagnostic difficulties and therapeutic constraints
Nephrol Ther. 2023 Nov 2;19(6):483-490. doi: 10.1684/ndt.2023.37.ABSTRACTAtypical Hemolytic Uremic Syndrome (aHUS) is a systemic disease due to dysregulation of the alternate complement pathway, mortality is estimated at 10% and more than 50% of patients progress to end-stage renal disease. The aim of this study was to summarize the clinical data and biological results as well as the evolution and management of patients with aHUS seen over a period of four years in one specialized department in Algeria. Our study was observational and longitudinal. The inclusion criteria were: the clinical-biological triad of aHUS and age ...
Source: Nephrologie and Therapeutique - November 2, 2023 Category: Urology & Nephrology Authors: Souad Chelghoum Farid Haddoum Kamel Djenouhat Mohamed-Taher Hamlaoui Nawel Adjlane Mourad Boukheloua Source Type: research
Atypical hemolytic and uremic syndrome in Algeria: diagnostic difficulties and therapeutic constraints
Nephrol Ther. 2023 Nov 2;19(6):483-490. doi: 10.1684/ndt.2023.37.ABSTRACTAtypical Hemolytic Uremic Syndrome (aHUS) is a systemic disease due to dysregulation of the alternate complement pathway, mortality is estimated at 10% and more than 50% of patients progress to end-stage renal disease. The aim of this study was to summarize the clinical data and biological results as well as the evolution and management of patients with aHUS seen over a period of four years in one specialized department in Algeria. Our study was observational and longitudinal. The inclusion criteria were: the clinical-biological triad of aHUS and age ...
Source: Nephrologie and Therapeutique - November 2, 2023 Category: Urology & Nephrology Authors: Souad Chelghoum Farid Haddoum Kamel Djenouhat Mohamed-Taher Hamlaoui Nawel Adjlane Mourad Boukheloua Source Type: research
Atypical hemolytic and uremic syndrome in Algeria: diagnostic difficulties and therapeutic constraints
Nephrol Ther. 2023 Nov 2;19(6):483-490. doi: 10.1684/ndt.2023.37.ABSTRACTAtypical Hemolytic Uremic Syndrome (aHUS) is a systemic disease due to dysregulation of the alternate complement pathway, mortality is estimated at 10% and more than 50% of patients progress to end-stage renal disease. The aim of this study was to summarize the clinical data and biological results as well as the evolution and management of patients with aHUS seen over a period of four years in one specialized department in Algeria. Our study was observational and longitudinal. The inclusion criteria were: the clinical-biological triad of aHUS and age ...
Source: Nephrologie and Therapeutique - November 2, 2023 Category: Urology & Nephrology Authors: Souad Chelghoum Farid Haddoum Kamel Djenouhat Mohamed-Taher Hamlaoui Nawel Adjlane Mourad Boukheloua Source Type: research
Atypical hemolytic and uremic syndrome in Algeria: diagnostic difficulties and therapeutic constraints
Nephrol Ther. 2023 Nov 2;19(6):483-490. doi: 10.1684/ndt.2023.37.ABSTRACTAtypical Hemolytic Uremic Syndrome (aHUS) is a systemic disease due to dysregulation of the alternate complement pathway, mortality is estimated at 10% and more than 50% of patients progress to end-stage renal disease. The aim of this study was to summarize the clinical data and biological results as well as the evolution and management of patients with aHUS seen over a period of four years in one specialized department in Algeria. Our study was observational and longitudinal. The inclusion criteria were: the clinical-biological triad of aHUS and age ...
Source: Nephrologie and Therapeutique - November 2, 2023 Category: Urology & Nephrology Authors: Souad Chelghoum Farid Haddoum Kamel Djenouhat Mohamed-Taher Hamlaoui Nawel Adjlane Mourad Boukheloua Source Type: research
Atypical hemolytic and uremic syndrome in Algeria: diagnostic difficulties and therapeutic constraints
Nephrol Ther. 2023 Nov 2;19(6):483-490. doi: 10.1684/ndt.2023.37.ABSTRACTAtypical Hemolytic Uremic Syndrome (aHUS) is a systemic disease due to dysregulation of the alternate complement pathway, mortality is estimated at 10% and more than 50% of patients progress to end-stage renal disease. The aim of this study was to summarize the clinical data and biological results as well as the evolution and management of patients with aHUS seen over a period of four years in one specialized department in Algeria. Our study was observational and longitudinal. The inclusion criteria were: the clinical-biological triad of aHUS and age ...
Source: Nephrologie and Therapeutique - November 2, 2023 Category: Urology & Nephrology Authors: Souad Chelghoum Farid Haddoum Kamel Djenouhat Mohamed-Taher Hamlaoui Nawel Adjlane Mourad Boukheloua Source Type: research
Atypical hemolytic and uremic syndrome in Algeria: diagnostic difficulties and therapeutic constraints
Nephrol Ther. 2023 Nov 2;19(6):483-490. doi: 10.1684/ndt.2023.37.ABSTRACTAtypical Hemolytic Uremic Syndrome (aHUS) is a systemic disease due to dysregulation of the alternate complement pathway, mortality is estimated at 10% and more than 50% of patients progress to end-stage renal disease. The aim of this study was to summarize the clinical data and biological results as well as the evolution and management of patients with aHUS seen over a period of four years in one specialized department in Algeria. Our study was observational and longitudinal. The inclusion criteria were: the clinical-biological triad of aHUS and age ...
Source: Nephrologie and Therapeutique - November 2, 2023 Category: Urology & Nephrology Authors: Souad Chelghoum Farid Haddoum Kamel Djenouhat Mohamed-Taher Hamlaoui Nawel Adjlane Mourad Boukheloua Source Type: research
Atypical hemolytic and uremic syndrome in Algeria: diagnostic difficulties and therapeutic constraints
Nephrol Ther. 2023 Nov 2;19(6):483-490. doi: 10.1684/ndt.2023.37.ABSTRACTAtypical Hemolytic Uremic Syndrome (aHUS) is a systemic disease due to dysregulation of the alternate complement pathway, mortality is estimated at 10% and more than 50% of patients progress to end-stage renal disease. The aim of this study was to summarize the clinical data and biological results as well as the evolution and management of patients with aHUS seen over a period of four years in one specialized department in Algeria. Our study was observational and longitudinal. The inclusion criteria were: the clinical-biological triad of aHUS and age ...
Source: Nephrologie and Therapeutique - November 2, 2023 Category: Urology & Nephrology Authors: Souad Chelghoum Farid Haddoum Kamel Djenouhat Mohamed-Taher Hamlaoui Nawel Adjlane Mourad Boukheloua Source Type: research
Atypical hemolytic and uremic syndrome in Algeria: diagnostic difficulties and therapeutic constraints
Nephrol Ther. 2023 Nov 2;19(6):483-490. doi: 10.1684/ndt.2023.37.ABSTRACTAtypical Hemolytic Uremic Syndrome (aHUS) is a systemic disease due to dysregulation of the alternate complement pathway, mortality is estimated at 10% and more than 50% of patients progress to end-stage renal disease. The aim of this study was to summarize the clinical data and biological results as well as the evolution and management of patients with aHUS seen over a period of four years in one specialized department in Algeria. Our study was observational and longitudinal. The inclusion criteria were: the clinical-biological triad of aHUS and age ...
Source: Nephrologie and Therapeutique - November 2, 2023 Category: Urology & Nephrology Authors: Souad Chelghoum Farid Haddoum Kamel Djenouhat Mohamed-Taher Hamlaoui Nawel Adjlane Mourad Boukheloua Source Type: research
Atypical hemolytic and uremic syndrome in Algeria: diagnostic difficulties and therapeutic constraints
Nephrol Ther. 2023 Nov 2;19(6):483-490. doi: 10.1684/ndt.2023.37.ABSTRACTAtypical Hemolytic Uremic Syndrome (aHUS) is a systemic disease due to dysregulation of the alternate complement pathway, mortality is estimated at 10% and more than 50% of patients progress to end-stage renal disease. The aim of this study was to summarize the clinical data and biological results as well as the evolution and management of patients with aHUS seen over a period of four years in one specialized department in Algeria. Our study was observational and longitudinal. The inclusion criteria were: the clinical-biological triad of aHUS and age ...
Source: Nephrologie and Therapeutique - November 2, 2023 Category: Urology & Nephrology Authors: Souad Chelghoum Farid Haddoum Kamel Djenouhat Mohamed-Taher Hamlaoui Nawel Adjlane Mourad Boukheloua Source Type: research
